Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stent implantation in a real-world population: A comparison with paclitaxel-eluting stents: The pori registry

Journal of Interventional Cardiology

Volumn 24, Issue 1, 2011, Pages 1-8

  Karjalainen, Pasi P ^a   Ylitalo, Antti ^a   Airaksinen, Juhani Ke ^b   Nammas, Wail ^c  

^a SATAKUNTA CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c Saint Fatima Square Heliopolis   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; PACLITAXEL; TITANIUM;

AGED; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TITANIUM NITRIDE OXIDE COATED BIOACTIVE STENT;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PACLITAXEL; PROPENSITY SCORE; PROSPECTIVE STUDIES; REGISTRIES; TIME FACTORS; TITANIUM; TREATMENT OUTCOME;

EID: 79951667924     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2010.00601.x     Document Type: Article

References (37)

1. Fischman DL, Leon MB, Baim DS, et al,. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501. (Pubitemid 24256752)
2. Serruys PW, de Jaegere P, Kiemeneij F, et al,. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-495. (Pubitemid 24256751)
3. Peterson ED, Cowper PA, DeLong ER, et al,. Acute and long-term cost implications of coronary stenting. J Am Coll Cardiol 1999; 33: 1610-1618.
4. Al Suwaidi J, Berger PB, Holmes DR Jr,. Coronary artery stents. JAMA 2000; 284: 1828-1836.
5. Abizaid A, Kornowski R, Mintz GS, et al,. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998; 32: 584-589. (Pubitemid 28435240)
6. Kastrati A, Hall D, Schömig A,. Long-term outcome after coronary stenting. Curr Control Trials Cardiovasc Med 2000; 1: 48-54. (Pubitemid 32223451)
7. Moses JW, Leon MB, Popma JJ, et al,. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323. (Pubitemid 37186209)
8. Stone GW, Ellis SG, Cox DA, et al,. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231. (Pubitemid 38067635)
9. Nordmann AJ, Briel M, Bucher HC,. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: A meta-analysis. Eur Heart J 2006; 27: 2784-2814. (Pubitemid 44871464)
10. Camenzind E, Steg PG, Wijns W,. Stent thrombosis late after implantation of first generation drug-eluting stents: A cause for concern. Circulation 2007; 115: 1440-1455. (Pubitemid 46648381)
11. Lagerqvist B, James SK, Stenestrand U, et al,. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007; 356: 1009-1019. (Pubitemid 46376801)
12. Windecker S, Simon R, Lins M, et al,. Randomized comparison of a titanium-nitride oxide-coated stent with a stainless steel stent for coronary revascularization. The TINOX trial. Circulation 2005; 111: 2617-2622. (Pubitemid 40740861)
13. Karjalainen PP, Ylitalo A, Airaksinen KE,. Real world experience with the TITAN stent: A 9-month follow-up report from the Titan PORI registry. EuroInterv 2006; 2: 187-191.
14. Mosseri M, Miller H, Tamari I, et al,. The titanium-NO stent: Results of a multicenter registry. EuroInterv 2006; 2: 192-196.
15. Mosseri M, Tamari I, Plich M, et al,. Short and long term outcome of the Titanium-NO stent registry. Cardiovasc Revasc Med 2005; 6: 2-6. (Pubitemid 41262612)
16. Giraud-Sauveur Y,. Titan 2 Bioactive stent (BAS) with titanium-NO. EuroInterv 2007; 3: 526-528.
17. Karjalainen PP, Ylitalo A, Airaksinen JK,. Titanium and nitride oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. J Invasive Cardiol 2006; 18: 462-468. (Pubitemid 44497335)
18. Karjalainen PP, Annala AP, Ylitalo A, et al,. Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. Int J Cardiol 2009; doi:.
19. Buehl A, Zoefel P,. SPSS 11: Introduction in Modern Data Analysis. 8th ed. Munich, Germany: Addison-Wesley, 2002.
20. Stone GW, Moses JW, Ellis SG, et al,. Safety and efficacy of sirolimus- and paclitaxel eluting coronary stents. N Engl J Med 2007; 356: 998-1008. (Pubitemid 46376800)
21. Mauri L, Hsieh W, Massaro JM, et al,. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-1029. (Pubitemid 46376802)
22. Daemen J, Wenaweser P, Tsuchida K, et al,. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007; 369: 667-678. (Pubitemid 46281313)
23. Daemen J, Tanimoto S, García-García HM, et al,. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-Search Registries). Am J Cardiol 2007; 99: 1027-1032. (Pubitemid 46560473)
24. Wenaweser P, Daemen J, Zwahlen M, et al,. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. J Am Coll Cardiol 2008; 52: 1134-1140.
25. Virmani R, Guagliumi G, Farb A, et al,. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? Circulation 2004; 109: 701-705. (Pubitemid 38222887)
26. Finn AV, Nakazawa G, Joner M, et al,. Vascular responses to drug eluting stents. Importance of delayed healing. Arterioscler Thromb Vasc Biol 2007; 27: 1500-1510. (Pubitemid 46986103)
27. Daemen J, Serruys PW,. Drug-eluting stent update 2007: Part II: Unsettled issues. Circulation 2007; 116: 961-968. (Pubitemid 47300921)
28. Windecker S,. Randomized Comparison of Titanium-nitride-oxide Coated Stents with Zotarolimus-eluting Stents for Coronary Revascularization. Paris, France: EuroPCR, 2010.
29. Babapulle MN, Joseph L, Belisle P, et al,. A hierarchical Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 2004; 364: 583-591. (Pubitemid 39094175)
30. Morice MC, Serruys PW, Sousa JE, et al., Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
31. Spertus JA, Kettelkamp R, Vance C, et al,. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER registry. Circulation 2006; 113: 2803-2809. (Pubitemid 44305292)
32. Iakovou I, Schmidt T, Bonizzoni E, et al,. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130. (Pubitemid 40617065)
33. Steinemann SG,. Metal implants and surface reactions. Injury 1996; 27 (Suppl. 3): SC16-22.
34. Hung-I Y, Shao-Kou L, Tin-Yi T, et al,. Comparison of endothelial cells grown on different stent materials. J Biomed Mater Res A 2006; 76: 835-841.
35. Karjalainen PP, Ylitalo A, Niemelä M, et al,. Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: A 12-months follow-up report from the TITAX AMI trial. EuroInterv 2008; 4: 234-241.
36. Karjalainen PP, Ylitalo A, Niemela M, et al,. Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction. Ann Med 2009; 21: 1-9.
37. Kaiser C, Brunner-La Rocca HP, Buser PT, et al,. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: Randomised Basel Stent Kosten Effektivitäts Trial (BASKET). Lancet 2005; 366: 921-929. (Pubitemid 41265666)